Related Experiment Video
Updated: Jul 11, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Outcomes of Endovascular Treatment for Critical Limb Threatening Ischemia
Adam Beucler1, Elias Wheibe2, Sagar S Gandhi2
1Department of Vascular Surgery/Medicine, Prisma Health System, Greenville, SC.
Insights
Endovascular therapy for critical limb threatening ischemia (CLTI) with ulceration shows high risks for amputation and mortality. Vigilant infection management is crucial for amputation prevention in CLTI patients.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Wound Care
Background:
- Critical limb threatening ischemia (CLTI) with ischemic ulceration is linked to high morbidity and mortality.
- Endovascular therapy has been the primary treatment, but its efficacy is under review following the BEST-CLI trial.
- This study evaluates outcomes of endovascular-first treatment in CLTI patients with ischemic ulceration.
Purpose of the Study:
- To assess the outcomes of endovascular-first therapy in patients with critical limb threatening ischemia and ischemic ulceration.
- To identify predictors of mortality and amputation-free survival in this patient cohort.
- To compare findings with the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Threatening Ischemia (BEST-CLI) trial.
Main Methods:
- Retrospective evaluation of 150 CLTI patients with ischemic ulceration treated with endovascular-first therapy.
- Analysis of patient demographics, co-morbidities, and anatomic severity using Society for Vascular Surgery criteria (Global Limb Anatomical Staging System).
- Kaplan-Meier survival analysis and logistic regression to identify predictors of mortality and amputation-free survival.
Main Results:
- The study included 150 patients (mean age 72 years), predominantly male, Caucasian, and ambulatory, with high rates of diabetes (67%) and smoking history (49%).
- A significant proportion (64.4%) had unfavorable anatomy (Global Limb Anatomical Staging System stages 2-3) for long-term patency.
- At 24 months, survival was 69%, amputation-free survival was 38%, and reintervention rates were 36%. Infection was a significant predictor of mortality and reduced amputation-free survival.
Conclusions:
- Endovascular treatment for CLTI with ischemic ulceration, even when technically successful, is associated with substantial risks of limb loss and mortality.
- Effective amputation prevention strategies must prioritize the management of infection.
- These findings support the applicability of patient-centered care informed by data from trials like BEST-CLI.
Background:
Critical limb threatening ischemia (CLTI), particularly in patients with ischemic ulceration has been associated with significant morbidity and mortality. Typically, endovascular therapy has been first-line therapy for our patients, but this strategy has come into question based upon the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Threatening Ischemia (BEST-CLI) trial data.
Methods And Results:
For comparative purposes, we evaluated outcomes from 150 CLTI patients with ischemic ulceration treated with endovascular-first therapy. The mean age was 72 years in this predominate male, Caucasian, ambulatory group. The major co-morbidities were smoking history in 49% and diabetes mellitus in 67%.` Anatomic scoring, using Society for Vascular Surgery criteria, revealed only 35.6% had favorable anatomy (Global Limb Anatomical Staging System stage of 0,1) for long-term patency compared to 64.4% of limbs with unfavorable anatomy for long-term patency (Global Limb Anatomical Staging System stage 2,3). Stents were used in 47% of cases. Reintervention occurred in 36% over 24 months follow-up. At 12 and 24 months, the Kaplan-Meier projections for survival was 0.80 (0.73, 0.87) and 0.69 (0.59, 0.79); amputation was 0.69 (0.61, 0.77) and 0.59 (0.46, 0.71); amputation-free survival (AFS) was 0.56 (0.48, 0.65) and 0.38 (0.27, 0.50), respectively. Amputation was more common in those with reinterventions (P = 0.033). Mortality was predicted with ankle brachial index ≤0.40 or ≥1.30 (P = 0.0019) and the presence of infection (P = 0.0047). AFS was predicted by the presence of any infection (P = 0.0001).
Conclusions:
Despite technically successful endovascular treatment, patients who present with CLTI maintain a high-risk for limb loss and mortality. Amputation prevention must vigilantly address infection risk. These data correlate with outcomes from BEST-CLI trial enhancing applicability to patient-centered care.
More Related Videos
07:48Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
Published on: June 8, 2019
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Aneurysm III: Interprofessional Care